Clinical efficacy of bortezomib and lenalidomide in blastic plasmacytoid dendritic cell neoplasm

Ann Hematol. 2019 Jun;98(6):1525-1527. doi: 10.1007/s00277-019-03623-z. Epub 2019 Jan 29.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Animals
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bees
  • Bone Marrow / pathology
  • Bortezomib / administration & dosage
  • Dendritic Cells / pathology*
  • Disease Progression
  • Drug Resistance, Neoplasm
  • Forearm Injuries / complications
  • Histiocytic Disorders, Malignant / complications
  • Histiocytic Disorders, Malignant / drug therapy*
  • Histiocytic Disorders, Malignant / pathology
  • Humans
  • Insect Bites and Stings / complications
  • Lenalidomide / administration & dosage
  • Male
  • Middle Aged
  • NF-kappa B / physiology
  • Neoplasm Proteins / physiology
  • Salvage Therapy*

Substances

  • NF-kappa B
  • Neoplasm Proteins
  • Bortezomib
  • Lenalidomide